The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular Carcinoma
Open accessAbstract
BACKGROUND & AIMS: Androgen effects on hepatocellular carcinoma (HCC) remain controversial and androgen ablation therapy to treat HCC also leads to inconsistent results. Here we examine androgen receptor (AR) roles in hepatocarcinogenesis using mice lacking AR in hepatocytes. METHODS: By using the Cre-Lox conditional knockout mice model injected with carcinogen, we examined the AR roles in hepatocarcinogenesis. We also tested the possible roles of AR in cellular oxidative stress and DNA damage sensing/repairing systems. By using AR degrading compound, ASC-J9, or AR-small interference RNA, we also examined the therapeutic potentials of targeting AR in HCC. RESULTS: We found AR expression was increased in human HCC compared with normal livers. We also found mice lacking hepatic AR developed later and less HCC than their wild-type littermates with comparable serum testosterone in both male and female mice. Addition of functional AR in human HCC cells also resulted in the promotion of cell growth in the absence or presence of 5alpha-dihydrotestosterone. Mechanistic dissection suggests that AR may promote hepatocarcinogenesis via increased cellular oxidative stress and DNA damage, as well as suppression of p53-mediated DNA damage sensing/repairing system and cell apoptosis. Targeting AR directly via either AR-small interference RNA or ASC-J9 resulted in suppression of HCC in both ex vivo cell lines and in vivo mice models. CONCLUSIONS: Our data point to AR, but not androgens, as a potential new and better therapeutic target for the battle of HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells
Jie, X., Lang, C., Jian, Q., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210362 · Cited by 42
RetractedMosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530
Maeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
Androgen Receptor (AR) Coregulators: An Overview
Heinlein, C. A., & Chang, C. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0460 · Cited by 943
Self-citationMolecular Cloning of Human and Rat Complementary DNA Encoding Androgen Receptors
Chang, C. S., Kokontis, J., & Liao, S. (1988) · Science · doi:10.1126/science.3353726 · Cited by 902
Self-citationNeuroprotection against Oxidative Stress by Estrogens: Structure-Activity Relationship
Behl, C., Skutella, T., Lezoualc’H, F., Post, A., Widmann, M., Newton, C. J., & Holsboer, F. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.4.535 · Cited by 762
Yeh, S., Tsai, M.-Y., Xu, Q., Mu, X.-M., Lardy, H., Huang, K.-E., Lin, H., Yeh, S.-D., Altuwaijri, S., Zhou, X., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212474399 · Cited by 668
Self-citation
Cited by
Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma
Feng, J., Li, J., Wu, L., Yu, Q., Ji, J., Wu, J., Dai, W., & Guo, C. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01629-4 · Cited by 699
Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets
Yang, Y., Kim, S., & Seki, E. (2019) · Seminars in Liver Disease · doi:10.1055/s-0038-1676806 · Cited by 449
Foxa1 and Foxa2 Are Essential for Sexual Dimorphism in Liver Cancer
Li, Z., Tuteja, G., Schug, J., & Kaestner, K. H. (2012) · Cell · doi:10.1016/j.cell.2011.11.026 · Cited by 382
Klein, S. L. (2012) · BioEssays · doi:10.1002/bies.201200099 · Cited by 284
Gender Disparity of Hepatocellular Carcinoma: The Roles of Sex Hormones
Yeh, S.-H., & Chen, P.-J. (2010) · Oncology · doi:10.1159/000315247 · Cited by 256
Self-citation
Metadata
- Authors
- Ma, W., Hsu, C., Wu, M., Wu, C., Wu, C., Lai, J., Jou, Y., Chen, C., Yeh, S., & Chang, C.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 135
- Issue
- 3
- Pages
- 947-955.e5
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2117502057
- Cited by
- 252
- References
- 33
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular Carcinoma. https://app.cochat.ai/papers/10.1053/j.gastro.2008.05.046
- The paper
- Ma, W., Hsu, C., Wu, M., Wu, C., Wu, C., Lai, J., Jou, Y., Chen, C., Yeh, S., & Chang, C. (2008). Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular Carcinoma. Gastroenterology. https://doi.org/10.1053/j.gastro.2008.05.046
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.